Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?

Anticancer Research

Volumn 21, Issue 3 C, 2001, Pages 2141-2147

  Ratnasinghe, D ^a   Daschner, P J ^a   Anver, M R ^a   Kasprzak, B H ^a   Taylor, P R ^a   Yeh, G C ^a   Tangrea, J A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Cyclooxygenase 2; Multi drug resistance; NSAIDs.

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; DOXORUBICIN; GLYCOPROTEIN P; PACLITAXEL; PROSTAGLANDIN E2; VINBLASTINE;

ARTICLE; BREAST CANCER; CANCER CELL; CORRELATION FUNCTION; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BREAST NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENZYME INDUCTION; GENE DOSAGE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; P-GLYCOPROTEIN; PARAFFIN EMBEDDING; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE C; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

EID: 0034897301     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Multidrug resistance in breast cancer: A meta-analysis of MDR1/gp170 expression and its possible functional significance
2. Expression of full length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin and vinblastin
3. A new functional role for P- glycoprotein: Efflux pump for benza(a)pyrene in human breast cancer MCF-7 cells
4. Protein Kinase C in adriamycin action and resistance in mouse sarcoma 180 cells
5. Role of protein kinase C in the modulation of multidrug resistance: Expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin
6. Differential expression and activity of phosphatases and protein kinases in adriamycin sensitive and resistant human breast cancer MCF-7 cells
7. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells
8. Expression of the antisense cDNA for protein kinase Caattenuates resistance in doxorubicin-Resistant MCF-7 breast carcinoma cells
9. Increased AP-1 a*ivity in drug resistant human breast cancer MCF-7 cells
10. Cancer of the breast
11. The interactions among steroid hormones, anti- estrogens, biological response modifiers and cytotoxic drugs in breast cancer
12. Mechanism of hormone and cyto-toxic drug interactions in the development and treatment of breast cancer
13. Posttranscriptional control of glutathione S- transferase pi gene expression in human breast cancer cells
14. Glutathione transferase GST pi in breast tumors evaluated by three techniques
15. Resistance to TNF-a and adriamycin in the human breast cancer MCF-7 cell line: Relationship to MDR1, MnSOD, and TNF gene expression
16. Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: Correlation with clinico-pathological features
17. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell lineselected for etoposide resistance
18. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance toantiestrogens and hormone-independent tumor growth in vivo
19. Role of NF-kB in phorbol ester- induced expression cyclooxygenase-2 and inducible nitric-oxide synthase in mouse skin
20. Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells
21. Microtubule interfering agents activate Cox-2 transcription in human mammary epithelial cells
22. Enhanced antitumor activity by co-administration of celecoxib and the chemotherapeutic agents cyclophosphamide and 5-FU
23. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells